{"title":"RNA效应物的治疗递送:影响呼吸系统的疾病。","authors":"Rima Kandil, M. Merkel","doi":"10.1691/PH.2016.5740","DOIUrl":null,"url":null,"abstract":"Although there are several hurdles to overcome on the way to the lung, this target organ provides several advantages for successful drug absorption. Recent findings in this field of research give reason to assume that the pulmonary delivery of RNA effector molecules holds a promising potential for the treatment of numerous severe respiratory diseases.","PeriodicalId":86039,"journal":{"name":"Die Pharmazie. Beihefte","volume":"84 1","pages":"21-6"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"8","resultStr":"{\"title\":\"Therapeutic delivery of RNA effectors: diseases affecting the respiratory system.\",\"authors\":\"Rima Kandil, M. Merkel\",\"doi\":\"10.1691/PH.2016.5740\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Although there are several hurdles to overcome on the way to the lung, this target organ provides several advantages for successful drug absorption. Recent findings in this field of research give reason to assume that the pulmonary delivery of RNA effector molecules holds a promising potential for the treatment of numerous severe respiratory diseases.\",\"PeriodicalId\":86039,\"journal\":{\"name\":\"Die Pharmazie. Beihefte\",\"volume\":\"84 1\",\"pages\":\"21-6\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Die Pharmazie. Beihefte\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1691/PH.2016.5740\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Die Pharmazie. Beihefte","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1691/PH.2016.5740","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Therapeutic delivery of RNA effectors: diseases affecting the respiratory system.
Although there are several hurdles to overcome on the way to the lung, this target organ provides several advantages for successful drug absorption. Recent findings in this field of research give reason to assume that the pulmonary delivery of RNA effector molecules holds a promising potential for the treatment of numerous severe respiratory diseases.